Total Payments
$722.63
2023 Payments
$25.81
Companies
9
Transactions
35
Medicare Patients
3,279
Medicare Billing
$375,737
Payment Breakdown by Category
Food & Beverage$709.67 (98.2%)
Education$12.96 (1.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $709.67 | 34 | 98.2% |
| Education | $12.96 | 1 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $246.72 | 5 | $0 (2023) |
| AbbVie, Inc. | $236.76 | 13 | $0 (2019) |
| PFIZER INC. | $69.53 | 5 | $0 (2020) |
| Janssen Biotech, Inc. | $50.73 | 4 | $0 (2019) |
| Endogastric Solutions, Inc | $44.50 | 3 | $0 (2020) |
| UCB, Inc. | $36.46 | 2 | $0 (2018) |
| Intercept Pharmaceuticals, Inc. | $14.48 | 1 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $12.96 | 1 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $10.49 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $25.81 | 1 | Boston Scientific Corporation ($25.81) |
| 2022 | $26.12 | 2 | Boston Scientific Corporation ($13.16) |
| 2020 | $123.90 | 5 | Boston Scientific Corporation ($59.08) |
| 2019 | $66.58 | 5 | PFIZER INC. ($28.16) |
| 2018 | $332.27 | 11 | BOSTON SCIENTIFIC CORPORATION ($134.65) |
| 2017 | $147.95 | 11 | AbbVie, Inc. ($92.17) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/22/2023 | Boston Scientific Corporation | EXALT Model D (Device) | Food and Beverage | In-kind items and services | $25.81 | General |
| Category: EXALT_ENDO | ||||||
| 10/18/2022 | Boston Scientific Corporation | Gold Probe (Device) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Gold Probe_ENDO | ||||||
| 05/06/2022 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Education | In-kind items and services | $12.96 | General |
| Category: Neuroscience | ||||||
| 11/02/2020 | Endogastric Solutions, Inc | ESOPHYX (Device) | Food and Beverage | Cash or cash equivalent | $20.54 | General |
| Category: GERD | ||||||
| 06/26/2020 | Endogastric Solutions, Inc | ESOPHYX (Device) | Food and Beverage | Cash or cash equivalent | $16.12 | General |
| Category: GERD | ||||||
| 02/24/2020 | PFIZER INC. | XELJANZ (Drug), INFLECTRA | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 01/30/2020 | Boston Scientific Corporation | ACQUIRE (Device) | Food and Beverage | In-kind items and services | $59.08 | General |
| Category: BIOPSY | ||||||
| 01/13/2020 | PFIZER INC. | XELJANZ (Drug), INFLECTRA | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/23/2019 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $11.91 | General |
| Category: Immunology | ||||||
| 08/29/2019 | PFIZER INC. | XELJANZ (Drug), INFLECTRA | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 06/13/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Entyvio (Biological) | Food and Beverage | In-kind items and services | $10.49 | General |
| Category: Lower GI | ||||||
| 05/01/2019 | PFIZER INC. | XELJANZ (Drug), INFLECTRA | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 04/17/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Immunology | ||||||
| 11/09/2018 | Endogastric Solutions, Inc | ESOPHYX (Device) | Food and Beverage | Cash or cash equivalent | $7.84 | General |
| Category: GERD | ||||||
| 09/05/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Immunology | ||||||
| 08/30/2018 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/22/2018 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: Immunology | ||||||
| 08/15/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Immunology | ||||||
| 06/06/2018 | Janssen Biotech, Inc. | STELARA (Biological), REMICADE | Food and Beverage | In-kind items and services | $11.67 | General |
| Category: Immunology | ||||||
| 05/16/2018 | Janssen Biotech, Inc. | STELARA (Biological), SIMPONI | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Immunology | ||||||
| 03/29/2018 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $79.43 | General |
| 03/15/2018 | BOSTON SCIENTIFIC CORPORATION | SPYGLASS (Device) | Food and Beverage | In-kind items and services | $134.65 | General |
| Category: BILIARY DEVICES | ||||||
| 03/15/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: Immunology | ||||||
| 02/22/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $8.20 | General |
| Category: Immunology | ||||||
| 12/13/2017 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $10.59 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 866 | 1,001 | $542,933 | $98,920 |
| 2022 | 15 | 918 | 1,019 | $512,967 | $99,296 |
| 2021 | 23 | 1,096 | 1,214 | $704,466 | $134,143 |
| 2020 | 12 | 399 | 449 | $190,897 | $43,378 |
Total Patients
3,279
Total Services
3,683
Medicare Billing
$375,737
Procedure Codes
65
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 342 | 360 | $182,781 | $38,559 | 21.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 184 | 297 | $79,198 | $19,483 | 24.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 95 | 95 | $59,185 | $7,367 | 12.4% |
| 45382 | Control of bleeding of upper large bowel using a flexible endoscope | Facility | 2023 | 24 | 25 | $29,150 | $5,462 | 18.7% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 39 | 39 | $31,977 | $5,380 | 16.8% |
| 43255 | Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 32 | 34 | $30,668 | $5,124 | 16.7% |
| 43264 | Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | Facility | 2023 | 15 | 15 | $24,588 | $4,056 | 16.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 13 | 13 | $14,924 | $2,673 | 17.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 21 | 21 | $18,306 | $2,625 | 14.3% |
| 43246 | Insertion of stomach tube using a flexible endoscope | Facility | 2023 | 15 | 15 | $13,665 | $2,581 | 18.9% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 27 | 27 | $14,877 | $1,984 | 13.3% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 11 | 12 | $8,964 | $1,578 | 17.6% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Facility | 2023 | 16 | 16 | $11,440 | $1,304 | 11.4% |
| 43262 | Incision of pancreatic outlet using a flexible endoscope | Facility | 2023 | 13 | 13 | $20,702 | $383.63 | 1.9% |
| 74328 | Review by radiologist of image from tube placement into bile duct using an endoscope | Facility | 2023 | 19 | 19 | $2,508 | $359.48 | 14.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 287 | 301 | $153,750 | $32,923 | 21.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 163 | 236 | $63,597 | $13,562 | 21.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 99 | 100 | $62,300 | $8,348 | 13.4% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 55 | 55 | $43,848 | $7,512 | 17.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 66 | 66 | $22,770 | $7,205 | 31.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 34 | 38 | $28,500 | $6,022 | 21.1% |
| 43255 | Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 34 | 34 | $30,668 | $5,316 | 17.3% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 42 | 44 | $24,244 | $3,553 | 14.7% |
| 45382 | Control of bleeding of upper large bowel using a flexible endoscope | Facility | 2022 | 15 | 15 | $17,490 | $3,291 | 18.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 29 | 34 | $7,072 | $2,669 | 37.7% |
About Dr. Vladimir Ferrer, DO
Dr. Vladimir Ferrer, DO is a Gastroenterology healthcare provider based in Fort Myers, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1952358921.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vladimir Ferrer, DO has received a total of $722.63 in payments from pharmaceutical and medical device companies, with $25.81 received in 2023. These payments were reported across 35 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($709.67).
As a Medicare-enrolled provider, Ferrer has provided services to 3,279 Medicare beneficiaries, totaling 3,683 services with total Medicare billing of $375,737. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology, Gastroenterology
- Location Fort Myers, FL
- Active Since 05/27/2006
- Last Updated 02/06/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1952358921
Products in Payments
- SPYGLASS (Device) $134.65
- Humira (Biological) $131.33
- XELJANZ (Drug) $69.53
- ACQUIRE (Device) $59.08
- STELARA (Biological) $50.73
- ESOPHYX (Device) $44.50
- Cimzia (Drug) $36.46
- Creon (Drug) $26.00
- EXALT Model D (Device) $25.81
- OCA (Drug) $14.48
- ADVANIX BILIARY STENT (Device) $14.02
- Gold Probe (Device) $13.16
- ZEPOSIA (Drug) $12.96
- Entyvio (Biological) $10.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Fort Myers
Randall Jacobs, Md, MD
Gastroenterology — Payments: $18,306
Gastroenterology $18,306
Juan Tejada-Almonte, M.d, M.D
Gastroenterology — Payments: $13,404
Gastroenterology $13,404
Dr. Augustine Salami, Md, MD
Gastroenterology — Payments: $10,902
Gastroenterology $10,902
Dr. Edward Jurkovic, D.o, D.O
Gastroenterology — Payments: $9,721
Gastroenterology $9,721
Robert Janda, Md, MD
Gastroenterology — Payments: $8,904
Gastroenterology $8,904
David Elliott, Do, DO
Gastroenterology — Payments: $8,680
Gastroenterology $8,680